A.R.T. Advisors’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
– Sell
-8,500
Closed -$396K – 1382
2019
Q3
$396K Sell
8,500
-7,000
-45% -$325K 0.02% 944
2019
Q2
$810K Buy
15,500
+7,100
+85% +$416K 0.05% 547
2019
Q1
$579K Buy
8,400
+2,100
+33% +$141K 0.03% 696
2018
Q4
$376K Sell
6,300
-3,300
-34% -$285K 0.02% 837
2018
Q3
$1.11M Buy
+9,600
New +$1.08M 0.05% 538
2018
Q2
– Sell
-5,500
Closed -$595K – 1463
2018
Q1
$595K Buy
+5,500
New +$609K 0.02% 877
2017
Q4
– Sell
-8,200
Closed -$809K – 1405
2017
Q3
$809K Sell
8,200
-1,100
-12% -$107K 0.04% 625
2017
Q2
$941K Buy
+9,300
New +$1M 0.05% 547
2016
Q4
– Sell
-3,600
Closed -$404K – 1292
2016
Q3
$404K Sell
3,600
-7,319
-67% -$843K 0.13% 244
2016
Q2
$1.35M Buy
+10,919
New +$1.32M 0.07% 433
2016
Q1
– Sell
-15,342
Closed -$1.67M – 1394
2015
Q4
$1.67M Buy
+15,342
New +$1.76M 0.08% 350
2015
Q3
– Sell
-32,489
Closed -$3.7M – 1381
2015
Q2
$3.7M Buy
+32,489
New +$3.94M 0.12% 231
2014
Q4
– Sell
-23,549
Closed -$3.45M – 1441
2014
Q3
$3.45M Sell
23,549
-13,988
-37% -$2.16M 0.16% 174
2014
Q2
$6.27M Buy
+37,537
New +$6.68M 0.33% 50
2014
Q1
– Sell
-3,820
Closed -$729K – 1351
2013
Q4
$729K Buy
+3,820
New +$711K 0.04% 623

Other funds holding CLB

A.R.T. Advisors's CLB Position: Q4 2019 in Review

A.R.T. Advisors sold out of Core Laboratories (CLB) in Q4 2019, closing a stake of 8,500 shares — an estimated $396K sold.

A.R.T. Advisors first reported a position in CLB in Q4 2013 and held it in 15 quarters. The position peaked at $6.27M in Q2 2014. 283 funds tracked by Wall St. Rank hold CLB as of Q4 2019.

  • A.R.T. Advisors reported no remaining Core Laboratories position as of Q4 2019 after selling out during the quarter.
  • A.R.T. Advisors sold 8,500 Core Laboratories shares in Q4 2019, an estimated $396K.
  • A.R.T. Advisors first reported a position in Core Laboratories in Q4 2013 and held it in 15 quarters.
  • A.R.T. Advisors's Core Laboratories position peaked at $6.27M in Q2 2014.
  • 283 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2019.

Based on A.R.T. Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.